Clinical Trials Browser

Phase 1 × Multiple Myeloma × Fibroblast Growth Factor 7 × Clear all

NCT00482846 2014-04-15

Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma

Phase 1 Completed

OtherPlasma cell

Multiple Myeloma, Mucositis, Drug-Related Side Effects and Adverse Reactions